Drreddys Laboratories | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
ANI Pharmaceuticals USD 144.86M 121K 2024-12
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bayer EUR 6.19B 1.57B 2024-12
Canopy Growth CAD 16.31M 69.8M 2024-12
Cipla INR 9.21B 2.81B 2024-09
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Drreddys Laboratories INR 1.1B 743M 2024-12
GlaxoSmithKline GBP 4.46B 594M 2025-03
Hikma Pharmaceutical USD 0 1000K 2024-06
Lonza CHF 1.11B 286M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pacira USD 276.77M 30.81M 2024-12
Prestige Brands USD 50.87M 666K 2024-12
Richter Gedeon HUF 135.63B 61.59B 2024-12
Sun Pharmaceuticals INR 80.13B 12.73B 2024-09
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Teva Pharmaceutical Industries USD 3.3B 19M 2024-12



Drreddys Laboratories Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.